Qingsu Cheng

Dr. Qingsu Cheng

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2025 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
MYMinxuan Yang
Minxuan Yang
YXYongbin Xu
Yongbin Xu
QCQingsu Cheng
Qingsu Cheng
YHYiruo He
Yiruo He
ZXZhilang Xu
Zhilang Xu
DLDefu Li
Defu Li

8 September 2021 in Cancers
Verified
Journal Article
Open access
PDF file
KJKosar Jabbari
Kosar Jabbari
GWGarrett Winkelmaier
Garrett Winkelmaier
CACody Andersen
Cody Andersen
YPYaswen Paul
Yaswen Paul
DQDavid Quilici
David Quilici
Bahram ParvinBahram Parvin
Bahram Parvin
Reprogramming the tumor stroma is an emerging approach to circumventing the challenges of conventional cancer therapies. This strategy, however, is hampered by the lack of a specific molecular target. We previously reported that stromal fibroblasts (FBs) with high expression of CD36 could be utilized for this purpose. These studies are now expanded to identify the secreted factors responsible for tumor suppression. Methodologies included 3D colonies, fluorescent microscopy coupled with quantitative techniques, proteomics profiling, and bioinformatics analysis. The results indicated that the conditioned medium (CM) of the CD36+ FBs caused growth suppression via apoptosis in the triple-negative cell lines of MDA-MB-231, BT549, and Hs578T, but not in the ERBB2+ SKBR3. Following the proteomics and bioinformatic analysis of the CM of CD36+ versus CD36− FBs, we determined KLF10 as one of the transcription factors responsible for growth suppression. We also identified FBLN1, SLIT3, and PENK as active ligands, where their minimum effective concentrations were determined. Finally, in MDA-MB-231, we showed that a mixture of FBLN1, SLIT3, and PENK could induce an amount of growth suppression similar to the CM of CD36+ FBs. In conclusion, our findings suggest that these ligands, secreted by CD36+ FBs, can be targeted for breast cancer treatment.

Verified
Journal Article
Open access
PDF file
KJKosar Jabbari
Kosar Jabbari
QCQingsu Cheng
Qingsu Cheng
GWGarrett Winkelmaier
Garrett Winkelmaier
Saori FurutaSaori Furuta
Saori Furuta
Bahram ParvinBahram Parvin
Bahram Parvin
Tumor and stroma coevolve to facilitate tumor growth. Hence, effective tumor therapeutics would not only induce growth suppression of tumor cells but also revert pro-tumor stroma into anti-tumoral type. Previously, we showed that coculturing triple-negative or luminal A breast cancer cells with CD36+ fibroblasts (FBs) in a three-dimensional extracellular matrix induced their growth suppression or phenotypic reversion, respectively. Then, we identified SLIT3, FBLN-1, and PENK as active protein ligands secreted from CD36+ FBs that induced growth suppression of MDA-MB-231 breast cancer cells and determined their minimum effective concentrations. Here, we have expanded our analyses to include additional triple-negative cancer cell lines, BT549 and Hs578T, as well as HCC1937 carrying a BRCA1 mutation. We show that the ectopic addition of each of the three ligands to cancer-associated fibroblasts (CAFs) elevates the expression of CD36, as well as the adipogenic marker FABP4. Lastly, we show that an agonist antibody for one of the PENK receptors induces growth suppression of all cancer cell lines tested but not for non-transformed MCF10A cells. These results clearly suggest that proteins secreted from CD36+ FBs induce not only growth suppression of tumor cells through binding the cognate receptors but also increasing adipogenic markers of CAFs to reprogram tumor stroma.

1 August 2024 in IEEE Access
Verified
Journal Article
Open access
ASAishwarya Shrestha
Aishwarya Shrestha
XBXuefeng Bao
Xuefeng Bao
QCQingsu Cheng
Qingsu Cheng
Susan McRoySusan McRoy
Susan McRoy
This research introduces an advanced approach to automate the segmentation and quantification of nuclei in fluorescent images through deep learning techniques. Overcoming inherent challenges such as variations in pixel intensities, noisy boundaries, and overlapping edges, our devised pipeline integrates the U-Net architecture with state-of-the-art CNN models, such as EfficientNet. This fusion maintains the efficiency of U-Net while harnessing the superior capabilities of EfficientNet. Crucially, we exclusively utilize high-quality confocal images generated in-house for model training, purposefully avoiding the pitfalls associated with publicly available synthetic data of lower quality. Our training dataset encompasses over 3000 nuclei boundaries, which are meticulously annotated manually to ensure precision and accuracy in the learning process. Additionally, post-processing is implemented to refine segmentation results, providing morphological quantification for each segmented nucleus. Through comprehensive evaluation, our model achieves notable performance metrics, attaining an F1-score of 87% and an Intersection over Union (IoU) value of 80%. Furthermore, its robustness is demonstrated across diverse datasets sourced from various origins, indicative of its broad applicability in automating nucleus extraction and quantification from fluorescent images. This innovative methodology holds significant promise for advancing research efforts across multiple domains by facilitating a deeper understanding of underlying biological processes through automated analysis of fluorescent imagery.

21 April 2026 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
YYYuhao Yuan
Yuhao Yuan
LZLinya Zeng
Linya Zeng
LYLun Yuan
Lun Yuan
QCQingsu Cheng
Qingsu Cheng
YCYibo Chen
Yibo Chen
DLDefu Li
Defu Li

9 November 2017 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
QCQingsu Cheng
Qingsu Cheng
Bahram ParvinBahram Parvin
Bahram Parvin
Rapid identification of bacteria can play an important role at the point of care, evaluating the health of the ecosystem, and discovering spatiotemporal distributions of a bacterial community. We introduce a method for rapid identification of bacteria in live cell assays based on cargo delivery of a nucleic acid sequence and demonstrate how a mixed culture can be differentiated using a simple microfluidic system. C60 Buckyballs are functionalized with nucleic acid sequences and a fluorescent reporter to show that a diversity of microorganisms can be detected and identified in live cell assays. The nucleic acid complexes include an RNA detector, targeting a species-specific sequence in the 16S rRNA, and a complementary DNA with an attached fluorescent reporter. As a result, each bacterium can be detected and visualized at a specific emission frequency through fluorescence microscopy. The C60 probe complexes can detect and identify a diversity of microorganisms that include gram-position and negative bacteria, yeast, and fungi. More specifically, nucleic-acid probes are designed to identify mixed cultures of Bacillus subtilis and Streptococcus sanguinis, or Bacillus subtilis and Pseudomonas aeruginosa. The efficiency, cross talk, and accuracy for the C60 probe complexes are reported. Finally, to demonstrate that mixed cultures can be separated, a microfluidic system is designed that connects a single source-well to multiple sinks wells, where chemo-attractants are placed in the sink wells. The microfluidic system allows for differentiating a mixed culture. The technology allows profiling of bacteria composition, at a very low cost, for field studies and point of care.